IQ EQ FUND MANAGEMENT (IRELAND) Ltd
Position in NRIX — Nurix Therapeutics, Inc.
CIK 1620943
DUBLIN 2, L2
Position in NRIX
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,180,610
+$913,330 QoQ
Shares Held
89,885
+9.9% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026IQ EQ FUND MANAGEMENT (IRELAND) Ltd holds $92,297,435 across 13 Biotechnology names. NRIX ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
381,991 | $20,833,789 | |
| 2 | TWST |
Twist Bioscience Corp
|
191,845 | $19,737,013 | |
| 3 | BEAM |
Beam Therapeutics Inc.
|
455,954 | $15,648,341 | |
| 4 | NTLA |
Intellia Therapeutics, Inc.
|
777,948 | $13,162,880 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
2,604,317 | $9,557,843 | |
| 6 | ABSI |
Absci Corp
|
478,520 | $5,546,046 | |
| 7 | NRIX |
Nurix Therapeutics, Inc.
This page
|
89,885 | $2,180,610 | |
| 8 | 252,913 | $1,332,851 |
All Filings in NRIX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,180,610 | 89,885 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,267,280 | 81,760 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,243,388 | 65,545 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $395,093 | 42,759 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $300,764 | 26,406 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $169,278 | 14,249 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||